Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

19 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Elavil Articles

US FDA to update black box warnings for young adults taking antidepressants

14 May 2007

Headlines 25 years ago this week....

22 January 2007

At least 20% of US seniors are given inappropriate scripts, new study finds

23 August 2004

Second FDA drug imports "blitz" finds 80% come from Canada

9 February 2004

Janssen-Cilag's topiramate expected to grow migraine prevention market

29 September 2003

US investigates W-L's Neurontin

6 April 2000

W-L's Neurontin efficacy vs amitriptyline?

16 September 1999

Some US PDR Info "Risks Patients' Lives"

10 February 1997

Forecasts For Growth In Euro Psychotropic Markets

22 August 1994

LUNDBECK PROFITS PLUNGE 81.2%IN 1992

17 May 1993

AXSAIN CREAM LAUNCHED IN UK

7 December 1992

TREATING DIABETIC NEUROPATHY

18 May 1992

Showing 1-12 of 12 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Encouraging results with Sangamo's SB-728-T in HIV treatment
  • Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
  • Bristol-Myers' data on Yervoy and nivolumab causes a stir
  • Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
  • Neovacs moving forward in rheumatoid arthritis, say analysts
  • Encouraging results with Sangamo's SB-728-T in HIV treatment
  • Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
  • Bristol-Myers' data on Yervoy and nivolumab causes a stir
  • Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
  • Neovacs moving forward in rheumatoid arthritis, say analysts

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS